LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2019

Apr 29, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2019-04-26

Reporting Person: Amouyal Philippe (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-04-26	Stock Option (Right to Buy)	$5.67	A	6519	Acquired	2029-04-26	Common Stock (6519)	Direct
2019-04-26	Restricted Stock Units	$	A	3466	Acquired		Common Stock (3466)	Direct

Footnotes

F1: Option vests with respect to one third of the shares subject to the option on each of the first three anniversaries of the grant date.

F2: Each restricted stock unit represents a contingent right to receive one share of common stock.

F3: Restricted stock unit vests with respect to 100% of the shares subject to the restricted stock unit on the first anniversary of the grant date.